339 related articles for article (PubMed ID: 31050209)
1. Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study.
Zumstein Camargo C; Kayser C
Int J Rheum Dis; 2019 Jul; 22(7):1319-1326. PubMed ID: 31050209
[TBL] [Abstract][Full Text] [Related]
2. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
[TBL] [Abstract][Full Text] [Related]
3. Nailfold capillaroscopy.
Smith V; Ickinger C; Hysa E; Snow M; Frech T; Sulli A; Cutolo M
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101849. PubMed ID: 37419757
[TBL] [Abstract][Full Text] [Related]
4. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
Lambova S; Hermann W; Muller-Ladner U
Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients.
Pizzorni C; Cutolo M; Sulli A; Ruaro B; Trombetta AC; Ferrari G; Pesce G; Smith V; Paolino S
Clin Rheumatol; 2018 Oct; 37(10):2723-2729. PubMed ID: 30006917
[TBL] [Abstract][Full Text] [Related]
6. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?
Cutolo M; Smith V
Rheumatology (Oxford); 2013 Nov; 52(11):1933-40. PubMed ID: 23620555
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud's phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study.
Amaral MC; Paula FS; Caetano J; Ames PR; Alves JD
Expert Rev Clin Immunol; 2024 Jun; 20(6):665-672. PubMed ID: 38465507
[TBL] [Abstract][Full Text] [Related]
8. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis.
Kayser C; Sekiyama JY; Próspero LC; Camargo CZ; Andrade LE
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):103-8. PubMed ID: 23324736
[TBL] [Abstract][Full Text] [Related]
9. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
[TBL] [Abstract][Full Text] [Related]
10. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.
Smith V; Riccieri V; Pizzorni C; Decuman S; Deschepper E; Bonroy C; Sulli A; Piette Y; De Keyser F; Cutolo M
J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778
[TBL] [Abstract][Full Text] [Related]
11. Reliability of widefield nailfold capillaroscopy and video capillaroscopy in the assessment of patients with Raynaud’s phenomenon.
Sekiyama JY; Camargo CZ; Eduardo L; Andrade C; Kayser C
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1853-61. PubMed ID: 23754794
[TBL] [Abstract][Full Text] [Related]
12. [Nailfold capillaroscopy: relevance to the practice of rheumatology].
Souza EJ; Kayser C
Rev Bras Reumatol; 2015; 55(3):264-71. PubMed ID: 25440704
[TBL] [Abstract][Full Text] [Related]
13. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
[TBL] [Abstract][Full Text] [Related]
14. Capillaroscopy.
Cutolo M; Pizzorni C; Secchi ME; Sulli A
Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
[TBL] [Abstract][Full Text] [Related]
15. Nailfold capillaroscopy in systemic diseases: short overview for internal medicine.
Dima A; Berza I; Popescu DN; Parvu MI
Rom J Intern Med; 2021 Sep; 59(3):201-217. PubMed ID: 33600677
[TBL] [Abstract][Full Text] [Related]
16. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.
Yalçınkaya Y; Adın-Çınar S; Artim-Esen B; Kamalı S; Pehlivan Ö; Öcal L; Deniz G; Inanç M
Microvasc Res; 2016 Nov; 108():17-21. PubMed ID: 27392528
[TBL] [Abstract][Full Text] [Related]
17. Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy.
Schioppo T; Orenti A; Boracchi P; De Lucia O; Murgo A; Ingegnoli F
Microvasc Res; 2019 Mar; 122():125-130. PubMed ID: 29981761
[TBL] [Abstract][Full Text] [Related]
18. Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis.
Keck AD; Foocharoen C; Rosato E; Smith V; Allanore Y; Distler O; Stamenkovic B; Pereira Da Silva JA; Hadj Khelifa S; Denisov LN; Hachulla E; García de la Peña Lefebvre P; Sibilia J; Airò P; Caramaschi P; Müller-Ladner U; Wiland P; Walker UA
Rheumatology (Oxford); 2014 Apr; 53(4):639-43. PubMed ID: 24310296
[TBL] [Abstract][Full Text] [Related]
19. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.
Ruaro B; Pizzorni C; Paolino S; Smith V; Ghio M; Casabella A; Alessandri E; Patané M; Sulli A; Cutolo M
Microvasc Res; 2019 Sep; 125():103874. PubMed ID: 30974112
[TBL] [Abstract][Full Text] [Related]
20. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.
Smith V; Herrick AL; Ingegnoli F; Damjanov N; De Angelis R; Denton CP; Distler O; Espejo K; Foeldvari I; Frech T; Garro B; Gutierrez M; Gyger G; Hachulla E; Hesselstrand R; Iagnocco A; Kayser C; Melsens K; Müller-Ladner U; Paolino S; Pizzorni C; Radic M; Riccieri V; Snow M; Stevens W; Sulli A; van Laar JM; Vonk MC; Vanhaecke A; Cutolo M;
Autoimmun Rev; 2020 Mar; 19(3):102458. PubMed ID: 31927087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
